Caribou Biosciences (CRBU) EBT Margin: 2020-2025
Historic EBT Margin for Caribou Biosciences (CRBU) over the last 6 years, with Sep 2025 value amounting to -1,337.58%.
- Caribou Biosciences' EBT Margin rose 55165.00% to -1,337.58% in Q3 2025 from the same period last year, while for Sep 2025 it was -1,708.08%, marking a year-over-year decrease of 26858.00%. This contributed to the annual value of -1,492.04% for FY2024, which is 119654.00% down from last year.
- As of Q3 2025, Caribou Biosciences' EBT Margin stood at -1,337.58%, which was up 25.02% from -1,783.95% recorded in Q2 2025.
- Caribou Biosciences' EBT Margin's 5-year high stood at -61.84% during Q3 2023, with a 5-year trough of -1,893.87% in Q1 2024.
- In the last 3 years, Caribou Biosciences' EBT Margin had a median value of -1,337.58% in 2025 and averaged -1,339.44%.
- Its EBT Margin has fluctuated over the past 5 years, first skyrocketed by 82,061bps in 2021, then crashed by 182,739bps in 2024.
- Over the past 5 years, Caribou Biosciences' EBT Margin (Quarterly) stood at -709.57% in 2021, then crashed by 11,865bps to -828.22% in 2022, then slumped by 22,411bps to -1,052.33% in 2023, then tumbled by 81,936bps to -1,871.69% in 2024, then spiked by 55,165bps to -1,337.58% in 2025.
- Its last three reported values are -1,337.58% in Q3 2025, -1,783.95% for Q2 2025, and -1,823.76% during Q1 2025.